- 全部删除
您的购物车当前为空
GSK805 是有效的、具有口服生物利用和中枢神经系统渗透性的 RORγt 抑制剂。

GSK805 是有效的、具有口服生物利用和中枢神经系统渗透性的 RORγt 抑制剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 491 | In stock | |
| 2 mg | ¥ 728 | In stock | |
| 5 mg | ¥ 1,230 | In stock | |
| 10 mg | ¥ 1,990 | In stock | |
| 25 mg | ¥ 3,770 | In stock | |
| 50 mg | ¥ 4,920 | In stock | |
| 100 mg | ¥ 6,990 | In stock | |
| 200 mg | ¥ 9,430 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,330 | In stock |
GSK805 相关产品
| 产品描述 | GSK805 is a potent, orally bioavailable and CNS-penetrant RORγt inhibitor. |
| 体外活性 | 方法: GSK805 (0.5 μM,4天)处理CD4 T 细胞(在 Th17 细胞分化条件下激活)。通过细胞内细胞因子染色测量 IL-17 和 IFNγ 的产生。 |
| 体内活性 | 方法: 诱导 C57BL/6 小鼠进行 EAE 并用 GSK805 (30 mg/kg,口服,14天) 处理。分离中枢神经系统浸润细胞,并通过细胞内染色测量 IL-17 和 IFNγ 的产生。 |
| 细胞实验 | CD4+CD62LhighCD25? naive CD4+ T cells were purified by FACS sorting following a MACS bead isolation of CD4+ cells. Naive CD4+ cells were activated with plate-bound anti-CD3 (2 μg/ml) and anti-CD28 (2 μg/ml). For Th17 cell differentiation, cultures were supplemented with IL-6 (20 ng/ml) plus TGF-β1 (1 ng/ml), and IL-23 (10 ng/ml) was added after 48 h. RORγt inhibitors or vehicle control DMSO was also included in the cultures. After 96 h, cells were collected for further experiments[1]. |
| 分子量 | 532.36 |
| 分子式 | C23H18Cl2F3NO4S |
| CAS No. | 1426802-50-7 |
| Smiles | CCS(=O)(=O)c1ccc(CC(=O)Nc2cc(Cl)c(c(Cl)c2)-c2ccccc2OC(F)(F)F)cc1 |
| 密度 | 1.434 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (187.84 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (18.78 mM), Suspension. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容